冷文修,高立建,杨跃进

• 1:国家心血管病中心北京协和医学院中国医学科学院阜外医院冠心病中心
• 2:解放军总医院第二医学中心心血管内科

摘要(Abstract)：

<正>1临床资料患者男,81岁。主因"反复活动后胸痛1周"于2018年11月9日入阜外医院住院治疗。患者入院1周前出现快走时胸痛,伴出汗、浑身发抖,休息后可迅速缓解,休息及夜间睡眠时无发作,可平卧。因以上症状反复发作,遂到当地医院就诊,行冠状动脉造影示:左前降支近中段重度狭窄伴弥漫钙化,左回旋支近中段重度狭窄,右冠状动脉近中段中度狭窄,后降支开口重度狭窄,给予药物治疗(具体不详)。次日凌晨1点睡眠中再发胸痛,伴出汗,含服速效救心丸后持续1 h左右方缓解,为进一步治疗转来阜外医院就诊。既往有高血压病、2型糖尿病、高脂血症及卒中病史多年。入院心电图示:V2～V6导联ST段压低0.05 mV。肌钙蛋白I

关键词(KeyWords)： 冠状动脉病变复杂;高危;适应证

Abstract:

Keywords:

基金项目(Foundation): 北京力生心血管健康基金会领航基金重点项目(LHJJ201510626)

作者(Author): 冷文修,高立建,杨跃进

参考文献(References)：

• [1] Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with STsegment elevation:the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC). Eur Heart J,2018,39(2):119-177.
• [2] Rihal CS, Naidu SS, Givertz MM, et al. 2015 SCAI/ACC/HFSA/STS Clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care:endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; A?rmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention. J Am Coll Cardiol,2015,65(19):e7-e26.
• [3] Cassese S, de Waha A, Ndrepepa G, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction without cardiogenic shock. A meta-analysis of randomized trials. Am Heart J,2012,164(1):58-65.
• [4] Romeo F, Acconcia MC, Sergi D, et al. Lack of intra-aortic balloon pump eff ectiveness in high-risk percutaneous coronary interventions without cardiogenic shock:a comprehensive meta-analysis of randomised trials and observational studies. Int J Cardiol,2013,167(5):1783-1793.
• [5] Grygier M, Araszkiewicz A, Lesiak M, et al. Role of adenosine as an adjunct therapy in the prevention and treatment of no-re?ow phenomenon in acute myocardial infarction with ST segment elevation:review of the current data. Kardiol Pol,2013,71(2):115-120.
• [6] Wang HJ, Lo PH, Lin JJ, et al. Treatment of slow/no-re?ow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction. Catheter Cardiovasc Interv,2004,63(2):171-176.
• [7] Zhao S, Qi G, Tian W, et al. Eff ect of intracoronary nitroprusside in preventing no re?ow phenomenon during primary percutaneous coronary intervention:a meta-analysis. J Interv Cardiol,2014,27(4):356-364.
• [8] Iwakura K, Ito H, Okamura A, et al. Nicorandil treatment in patients with acute myocardial infarction:a meta-analysis. Circ J,2009,73(5):925-931.
• [9]梁振洋，刘美丽，赵雪东，等.冠状动脉内注射比伐卢定预防直接经皮冠状动脉介入治疗术中无复流或慢血流的探索性临床研究.中国介入心脏病学杂志，2016,24(11):632-637.
• [10] Mongeon FP, Belisle P, Joseph L, et al. Adjunctive thrombectomy for acute myocardial infarction:A bayesian meta-analysis. Circ Cardiovasc Interv,2010,3(1):6-16.
• [11] Mancini JG, Filion KB, Windle SB, et al. Meta-analysis of the long-term effect of routine aspiration thrombectomy in patients undergoing primary percutaneous coronary intervention. Am J Cardiol,2016,118(1):23-31.